Anaesthesia product has potential in developing world:
This article was originally published in Clinica
Executive Summary
An anaesthesia system developed by a UK researcher that is claimed could revolutionise surgery in the developing world has been granted a UK NESTA funding award. Dr Paul Fenton, who has devised a low-cost system combining existing and new technology, has been awarded £33,000 ($47,000) to develop the device for use in remote locations where power supplies may be erratic. The device comprises an oxygen concentrator (not the conventional pipeline or cylinder gas supply), a "Fentolater" valve and modified mechanical ventolater. The NESTA (UK National Endowment for Science Technology and the Arts) award enables Dr Fenton to develop a prototype of the device over the next year.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.